Tirzepatide Cost: Brand vs Compounded — What You Need to Know in 2024

If you've been researching tirzepatide for weight loss or type 2 diabetes management, you've likely experienced sticker shock. The brand-name versions can cost well over $1,000 per month without insurance coverage. But there's another option gaining attention: compounded tirzepatide. Understanding the cost differences between brand-name and compounded versions can help you access this effective medication without breaking the bank.

Understanding Tirzepatide: The Basics

Tirzepatide is a dual GIP/GLP-1 receptor agonist that's changed the landscape of weight loss and diabetes treatment. It's sold under two brand names: Mounjaro (FDA-approved for type 2 diabetes) and Zepbound (FDA-approved specifically for weight management).

Both medications contain the exact same active ingredient and work identically in your body. The only real difference is the branding and the FDA-approved indication, which affects insurance coverage.

Brand-Name Tirzepatide Costs

Mounjaro and Zepbound Pricing

Without insurance or manufacturer savings programs, both Mounjaro and Zepbound typically cost between $1,050 and $1,350 per month. That's roughly $12,600 to $16,200 annually—a significant investment for most households.

The list price remains consistent regardless of your dosage level, whether you're starting at 2.5 mg or maintaining on 15 mg weekly injections.

Insurance Coverage Reality

Here's where things get complicated. Insurance coverage for brand-name tirzepatide varies dramatically:

• Mounjaro for type 2 diabetes: More likely to be covered, though many plans require prior authorization and proof that you've tried other medications first
• Zepbound for weight loss: Significantly less likely to be covered, as many insurance plans exclude weight loss medications entirely
• High deductibles: Even with coverage, you might pay full price until meeting your annual deductible
• Coverage changes: Plans frequently change their formularies, sometimes dropping coverage mid-treatment

Manufacturer Savings Programs

Eli Lilly offers savings cards that can reduce your cost to as low as $25 per month, but there are significant catches. These programs typically exclude anyone with government insurance (Medicare, Medicaid, Tricare), have income restrictions, and come with time limits—often 12-24 months maximum.

Once your eligibility ends, you're back to paying full price or scrambling for alternatives.

Compounded Tirzepatide Costs

What Is Compounded Tirzepatide?

Compounded medications are custom-prepared by licensed pharmacies using the same active pharmaceutical ingredient as brand-name drugs. Compounding pharmacies have been safely preparing customized medications for decades, particularly when commercial drugs are unavailable or cost-prohibitive.

During FDA-designated drug shortages—which both Mounjaro and Zepbound have experienced—compounding pharmacies are legally permitted to prepare tirzepatide formulations.

Compounded Tirzepatide Pricing

Compounded tirzepatide costs significantly less than brand-name versions, typically ranging from $99 to $500 per month depending on your provider and dosage level.

This pricing structure makes the medication accessible to many people who would otherwise be priced out of treatment entirely. The lower cost doesn't mean lower quality—it reflects reduced marketing expenses, no brand-name markup, and direct-to-consumer delivery models.

What's Included in Compounded Pricing

Reputable compounded tirzepatide programs typically include:

• The medication itself, shipped directly to your door
• Medical consultation and prescription from licensed physicians
• Dosing supplies (syringes, alcohol swabs, sharps container)
• Ongoing clinical support and dosage adjustments
• No hidden fees or surprise charges

Key Differences Beyond Price

FDA Approval Status

Brand-name Mounjaro and Zepbound are FDA-approved medications, meaning they've undergone rigorous clinical trials for safety and efficacy. Compounded tirzepatide uses the same active ingredient but isn't FDA-approved as a finished product.

However, reputable compounding pharmacies follow strict FDA regulations and use pharmaceutical-grade ingredients from FDA-registered facilities. They must also be licensed and regularly inspected.

Consistency and Convenience

Brand-name medications come in pre-filled, single-dose pens that are incredibly convenient—just twist, inject, and dispose. Compounded tirzepatide typically comes in vials requiring you to draw up your own dose with a syringe, which takes a bit more effort but is straightforward with proper instruction.

Some people actually prefer vials because they allow for more precise dosage adjustments, which can be helpful when titrating slowly to minimize side effects.

Who Benefits Most from Each Option?

Brand-Name May Be Better If:

• Your insurance covers it with reasonable copays
• You qualify for manufacturer assistance programs
• You strongly prefer maximum convenience with pre-filled pens
• You have concerns about using compounded medications

Compounded May Be Better If:

• You don't have insurance coverage for weight loss medications
• You've exhausted manufacturer savings programs
• You're comfortable with simple self-injection from a vial
• Cost is a significant barrier to accessing treatment

Gender Considerations in Tirzepatide Treatment

While tirzepatide works effectively for both men and women, research shows women may experience slightly higher rates of gastrointestinal side effects, particularly nausea. This sometimes means women benefit from slower dose escalation, which is easier to manage with compounded formulations that allow precise dosing adjustments.

Additionally, women often serve as healthcare decision-makers for their families, making cost considerations particularly important when budgeting for medical treatments.

Making Your Decision

The choice between brand-name and compounded tirzepatide ultimately comes down to access, affordability, and personal preference. Both options can be effective tools in your weight loss or diabetes management journey when prescribed and monitored by qualified healthcare providers.

Before deciding, consider your insurance situation, budget constraints, comfort level with each administration method, and the importance of FDA approval status versus cost savings.

The most important factor is finding an option you can afford consistently. Weight loss medications work best when taken continuously over time, so sustainable monthly costs matter more than any other single factor.

From the Ozari Care Team

When counseling patients on tirzepatide options, we emphasize that the best medication is the one you can afford to take consistently. Weight loss is a marathon, not a sprint, and interruptions in treatment often lead to weight regain. If compounded tirzepatide allows you to stay on treatment long-term where brand pricing would force you to stop, it's likely the better choice for your overall health outcomes.

Ready to Explore Your Options?

At Ozari Health, we offer compounded Semaglutide and Tirzepatide starting at $99/month, prescribed by licensed physicians and shipped to your door. Learn more at ozarihealth.com.

Medically reviewed by the Ozari Clinical Care Team, licensed physicians specializing in metabolic health and GLP-1 therapy. Last reviewed: April 26, 2026